LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
6.34
-0.18 (-2.76%)
At close: Jun 17, 2026, 4:00 PM EDT
6.47
+0.13 (2.05%)
After-hours: Jun 17, 2026, 7:47 PM EDT
LENZ Therapeutics Employees
LENZ Therapeutics had 152 employees as of December 31, 2025. The number of employees increased by 110 or 261.90% compared to the previous year.
Employees
152
Change (1Y)
110
Growth (1Y)
261.90%
Revenue / Employee
$138,086
Profits / Employee
-$717,079
Market Cap
198.79M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 152 | 110 | 261.90% |
| Dec 31, 2024 | 42 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Karyopharm Therapeutics | 228 |
| Coherus Oncology | 145 |
| Voyager Therapeutics | 141 |
| Arcturus Therapeutics Holdings | 111 |
| Keros Therapeutics | 87 |
| Cybin | 50 |
| Camp4 Therapeutics | 48 |
| Protara Therapeutics | 46 |
LENZ News
- 10 days ago - Lenz announces Everest Medicines acquired rights to develop VIZZ in China - TheFly
- 10 days ago - LENZ Therapeutics Announces Everest Medicines Acquired Rights to Develop and Commercialize VIZZ® (LNZ100) in Greater China - GlobeNewsWire
- 22 days ago - LENZ Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - Lenz Therapeutics price target lowered to $20 from $26 at Citi - TheFly
- 5 weeks ago - LENZ Therapeutics trading halted, volatility trading pause - TheFly
- 5 weeks ago - LENZ Therapeutics trading resumes - TheFly
- 5 weeks ago - Lenz Therapeutics price target raised to $31 from $29 at BofA - TheFly
- 5 weeks ago - Lenz Therapeutics price target lowered to $38 from $48 at H.C. Wainwright - TheFly